regeneron semaglutide pharmaceuticals announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Novel GLP-1 Pill Tops Oral

The drug class also includes Saxenda, Trulicity and Rybelsus

Glucagon receptor activation increases resting energy expenditure through multiple mechanisms, including enhanced hepatic metabolic activity, increased thermogenesis, and elevated fat oxidation rates

Many doctors might recommend combining medication like Ozempic with a Vitamin B12 supplement

How long until I see results with microdosing

As a co-founder and the CEO of Artisight, he is at the forefront of fusing deep learning and IoT sensors to facilitate healthcare automation and optimization

Since semaglutide mimics the hormone GLP-1, which regulates appetite, it helps someone feel full for longer, reduces cravings for ultra-processed foods, and slows gastric emptying